Detalles de la búsqueda
1.
Heparan sulfate is an attachment factor for foamy virus entry.
J Virol
; 86(18): 10028-35, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22787203
2.
A whole blood in vitro cytokine release assay with aqueous monoclonal antibody presentation for the prediction of therapeutic protein induced cytokine release syndrome in humans.
Cytokine
; 60(3): 828-37, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22986013
3.
Profound Functional Suppression of Tumor-Infiltrating T-Cells in Ovarian Cancer Patients Can Be Reversed Using PD-1-Blocking Antibodies or DARPin® Proteins.
J Immunol Res
; 2020: 7375947, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32832572
4.
Response to the letter to the editor by Susan Thorpe et al.: how predictive are in vitro assays for cytokine release syndrome in vivo? A comparison of methods reveals worrying differences in sensitivity and frequency of response.
Cytokine
; 64(1): 473-5; discussion 476, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23921146
5.
Rescued Chondrogenesis of Mesenchymal Stem Cells under Interleukin 1 Challenge by Foamyviral Interleukin 1 Receptor Antagonist Gene Transfer.
Front Pharmacol
; 8: 255, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28536528
6.
Aggregation of human recombinant monoclonal antibodies influences the capacity of dendritic cells to stimulate adaptive T-cell responses in vitro.
PLoS One
; 9(1): e86322, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24466023
Resultados
1 -
6
de 6
1
Próxima >
>>